It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
To date, no specific diagnostic criteria for sepsis-associated encephalopathy (SAE) have been established. We studied 33 pediatric patients with sepsis prospectively and evaluated the level of consciousness, the presence of delirium, electroencephalographic (EEG) findings, and plasma levels of neuron-specific enolase and S100-calcium-binding protein-B. A presumptive diagnosis of SAE was primarily considered in the presence of a decreased level of consciousness and/or delirium (clinical criteria), but specific EEG abnormalities were also considered (EEG criteria). The time course of the biomarkers was compared between groups with and without clinical or EEG criteria. The Functional Status Scale (FSS) was assessed at admission, discharge, and 3–6 months post-discharge. Clinical criteria were identified in 75.8% of patients, EEG criteria in 26.9%, both in 23.1%, and none in 23.1%. Biomarkers did not differ between groups. Three patients had an abnormal FSS at discharge, but no one on follow-up. A definitive diagnostic pattern for SAE remained unclear. Clinical criteria should be the basis for diagnosis, but sedation may be a significant confounder, also affecting EEG interpretation. The role of biomarkers requires a better definition. The diagnosis of SAE in pediatric patients remains a major challenge. New consensual diagnostic definitions and mainly prognostic studies are needed.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 D’Or Institute for Research & Education (IDOR), Department of Pediatrics, Rio de Janeiro, Brazil (GRID:grid.472984.4)
2 State Institute of the Brain Paulo Niemeyer, Department of Neurology, Rio de Janeiro, Brazil (GRID:grid.472984.4)
3 State University of Rio de Janeiro (UERJ), Department of Epidemiology, Institute of Social Medicine, Rio de Janeiro, Brazil (GRID:grid.412211.5) (ISNI:0000 0004 4687 5267); Naval Academy, Brazilian Navy, Department of Physical Education and Sports, Rio de Janeiro, Brazil (GRID:grid.412211.5)
4 Hospital Caxias D’Or, Pediatric Intensive Care Unit, Duque de Caxias, Brazil (GRID:grid.412211.5)
5 Hospital Rios D’Or, Pediatric Intensive Care Unit, Rio de Janeiro, Brazil (GRID:grid.412211.5)
6 D’Or Institute for Research & Education (IDOR), Department of Pediatrics, Rio de Janeiro, Brazil (GRID:grid.472984.4); Federal University of Rio de Janeiro (UFRJ), Instituto de Puericultura e Pediatria Martagão Gesteira, Rio de Janeiro, Brazil (GRID:grid.8536.8) (ISNI:0000 0001 2294 473X)
7 Federal University of Rio de Janeiro (UFRJ), Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Rio de Janeiro, Brazil (GRID:grid.8536.8) (ISNI:0000 0001 2294 473X); Carlos Chagas Filho Foundation for Supporting Research, State of Rio de Janeiro (FAPERJ), Rio de Janeiro Network on Neuroinflammation, Rio de Janeiro, Brazil (GRID:grid.452991.2) (ISNI:0000 0000 8484 4876)
8 Oswaldo Cruz Institute (FIOCRUZ), Immunopharmacology Laboratory, Rio de Janeiro, Brazil (GRID:grid.418068.3) (ISNI:0000 0001 0723 0931); D’Or Institute for Research & Education (IDOR), Department of Intensive Care Medicine, Rio de Janeiro, Brazil (GRID:grid.472984.4)
9 Oswaldo Cruz Institute (FIOCRUZ), Immunopharmacology Laboratory, Rio de Janeiro, Brazil (GRID:grid.418068.3) (ISNI:0000 0001 0723 0931)